Pandemic Response Box® library as a source of antifungal drugs against Scedosporium and Lomentospora species.
Rodrigo Rollin-PinheiroMariana Ingrid Dutra da Silva XistoYuri de Castro-AlmeidaVictor Pereira RochettiLuana Pereira Borba-SantosYasmin da Silva FontesAntonio Ferreira-PereiraSonia RozentalEliana Barreto-BergterPublished in: PloS one (2023)
Scedosporium and Lomentospora species are opportunistic filamentous fungi that cause localized and disseminated infections in immunocompetent and immunocompromised patients. These species are considered resistant fungi due to their low susceptibility to most current antifungal agents used in healthcare settings. The search for new compounds that could work as promising candidate antifungal drugs is an increasing field of interest. In this context, in the present study we screened the Pandemic Response Box® library (Medicines for Malaria Venture [MMV], Switzerland) to identify compounds with antifungal activity against Scedosporium and Lomentospora species. An initial screening of the drugs from this collection at 5 μM was performed using a clinical Scedosporium aurantiacum isolate according to the EUCAST protocol. Compounds with activity against this fungus were also tested against four other species (S. boydii¸ S. dehoogii, S. apiospermum and L. prolificans) at concentrations ranging from 0.078 to 10 μM. Seven compounds inhibited more than 80% of S. aurantiacum growth, three of them (alexidine, amorolfine and olorofim) were selected due to their differences in mechanism of action, especially when compared to drugs from the azole class. These compounds were more active against biofilm formation than against preformed biofilm in Scedosporium and Lomentospora species, except alexidine, which was able to decrease preformed biofilm about 50%. Analysis of the potential synergism of these compounds with voriconazole and caspofungin was performed by the checkerboard method for S. aurantiacum. The analysis by Bliss methodology revealed synergistic effects among selected drugs with caspofungin. When these drugs were combined with voriconazole, only alexidine and amorolfine showed a synergistic effect, whereas olorofim showed an antagonistic effect. Scanning electron microscopy revealed that alexidine induces morphology alterations in S. aurantiacum biofilm grown on a catheter surface. Reactive oxygen species production, mitochondrial activity and surface components were analyzed by fluorescent probes when S. aurantiacum was treated with selected drugs and revealed that some cell parameters are altered by these compounds. In conclusion, alexidine, amorolfine and olorofim were identified as promising compounds to be studied against scedosporiosis and lomentosporiosis.
Keyphrases
- candida albicans
- biofilm formation
- pseudomonas aeruginosa
- staphylococcus aureus
- healthcare
- single cell
- sars cov
- reactive oxygen species
- electron microscopy
- randomized controlled trial
- end stage renal disease
- oxidative stress
- transcription factor
- newly diagnosed
- escherichia coli
- genetic diversity
- mesenchymal stem cells
- stem cells
- small molecule
- risk assessment
- prognostic factors
- chronic kidney disease
- cell therapy
- mass spectrometry
- drug delivery
- peritoneal dialysis
- cancer therapy
- single molecule
- climate change
- social media
- human health
- living cells
- health information
- photodynamic therapy